MYO16
Basic information
Region (hg38): 13:108596152-109208005
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYO16 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 23 | 20 | 43 | |||
missense | 114 | 18 | 14 | 147 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 3 | 6 | 9 | |||
non coding | 4 | |||||
Total | 0 | 1 | 115 | 43 | 36 |
Variants in MYO16
This is a list of pathogenic ClinVar variants found in the MYO16 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-108629849-C-T | not specified | Uncertain significance (Dec 05, 2024) | ||
13-108665911-T-C | MYO16-related disorder | Benign (Dec 31, 2019) | ||
13-108665916-C-A | not specified | Uncertain significance (Jan 09, 2024) | ||
13-108665917-C-G | Likely benign (Sep 21, 2018) | |||
13-108665940-G-A | not specified | Uncertain significance (Oct 08, 2024) | ||
13-108665952-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
13-108665961-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
13-108665968-A-G | MYO16-related disorder | Benign (Apr 05, 2019) | ||
13-108665976-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
13-108666022-G-A | MYO16-related disorder | Benign (Dec 31, 2019) | ||
13-108666025-C-T | Benign (Dec 31, 2019) | |||
13-108666060-A-C | not specified | Uncertain significance (Sep 03, 2024) | ||
13-108666084-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
13-108666104-A-G | not specified | Likely benign (Feb 03, 2022) | ||
13-108712653-G-T | MYO16-related disorder | Likely benign (Oct 28, 2019) | ||
13-108712701-C-T | Likely benign (Dec 13, 2018) | |||
13-108712702-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
13-108727441-G-T | not specified | Uncertain significance (Feb 23, 2023) | ||
13-108727458-G-T | not specified | Uncertain significance (Apr 11, 2023) | ||
13-108727495-A-G | not specified | Uncertain significance (Dec 13, 2023) | ||
13-108727509-G-A | not specified | Uncertain significance (Mar 08, 2024) | ||
13-108727551-G-A | not specified | Uncertain significance (Mar 29, 2024) | ||
13-108785665-A-G | not specified | Uncertain significance (Jan 25, 2024) | ||
13-108785736-T-A | MYO16-related disorder | Benign (Oct 18, 2019) | ||
13-108793536-C-T | not specified | Uncertain significance (Feb 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYO16 | protein_coding | protein_coding | ENST00000356711 | 34 | 611856 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00149 | 125710 | 0 | 38 | 125748 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.03 | 917 | 1.01e+3 | 0.909 | 0.0000576 | 12060 |
Missense in Polyphen | 267 | 377.53 | 0.70723 | 4647 | ||
Synonymous | -0.143 | 429 | 425 | 1.01 | 0.0000279 | 3597 |
Loss of Function | 7.20 | 16 | 89.5 | 0.179 | 0.00000485 | 1061 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000242 | 0.000241 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000376 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000163 | 0.000158 |
Middle Eastern | 0.000376 | 0.000326 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000531 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. May be involved in targeting of the catalytic subunit of protein phosphatase 1 during brain development. Activates PI3K and concomitantly recruits the WAVE1 complex to the close vicinity of PI3K and regulates neuronal morphogenesis (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0927
Intolerance Scores
- loftool
- 0.234
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.53
Haploinsufficiency Scores
- pHI
- 0.365
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.186
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Myo16
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of cell population proliferation;cerebellum development;negative regulation of G1/S transition of mitotic cell cycle
- Cellular component
- nucleoplasm;cytoplasm;plasma membrane;myosin complex;perinuclear region of cytoplasm
- Molecular function
- motor activity;protein binding;ATP binding;actin filament binding